In the current study we addressed the question whether IL-2 treatment leads to an expansion of fully functional Treg cells in colorectal cancer patients and whether an increase of Treg cells in colorectal cancer patients is due to peripheral or thymic expansion. This evidence concerns the gene IL2 and colorectal cancer.